Retrospective Study Suggests that Stereotactic Ablative Radiotherapy (SABR) Can be a Viable Option for Treating Early-Stage Lung Cancer in Operable as well as Inoperable Patients; Phase III Randomized Trial Now Under Way

Symposium Speakers Summarize Recent and Current Research into Treating Early-Stage Lung Cancer with Radiosurgical Approaches

May 01, 2012, 08:00 ET from Varian Medical Systems, Inc.

$countyNameToPathMap.put("sp